Dr. Paweena Susantitaphong received her medical degree (with First Class Honors) from the Chulalongkorn University in 2002. She trained in Internal Medicine at the Khon Kaen University in Thailand, and later specialized in Clinical Nephrology at the Chulalongkorn University. She was also a visiting fellow at the University Hospital Ghent in Belgium. She received International Society of Nephrology COMGAN Fellowship Award in 2011-2012. She recently completed a Clinical Research Fellowship at the St. Elizabeth’s Medical Center, Tufts University School of Medicine in Boston, Massachusetts, USA and she has been an adjunct associate professor at Tufts University School of Medicine, Boston, USA. She graduated with a PhD in Biomedical Sciences from Chulalongkorn University in 2013. She has been promoted to Professor of Medicine since 2018 and is also Director of Research Unit for Metabolic Bone Disease in CKD Patients, Faculty of Medicine, Chulalongkorn University. Recently, she is the committee of Executive Director, The Nephrology Society of Thailand and the chairman of the Research and Professional Standards Sub-Committee, The Nephrology Society of Thailand.Dr. Susantitaphong’s major research interests include Acute kidney injury including early detection; biomarkers of kidney injury; genetic polymorphisms; early treatment strategies, hemodialysis and chronic kidney disease-mineral and bone disease. She is also interested in doing evidence-based medicine analysis especially systematic review and meta-analysis.Dr. Susantitaphong has contributed more than 50 chapters in medical textbooks and has published over 110 articles in various regional and international peer-reviewed journals as well as more than 3,000 citations. In 2022, she received World’s Top 2% Scientists (publications and citations) by Elsevier data update (Stanford University). She is an ad-hoc reviewer for several scientific journals (more than 15 journals such as Kidney International, American Journal of Kidney Diseases, Nephrology Dialysis Transplantation. She has had several oral and poster presentations and is also regularly invited as a speaker in national and international medical meetings and conferences (more than 300 times).
31 MARCH 2023
Time |
Session |
|
11:45
12:45
|
-
Gut-derived Uremic Toxins
-
Uremic Toxins and Peripheral Artery Disease
-
Uremic Toxins and Endothelium
-
Q and A
MR 111
|